| Title |
Date |
| Appendix 4D and Half-Year Financial Report |
February 18, 2020 |
| Investor Presentation Half Year FY2020 |
February 18, 2020 |
| Core revenue growth up 19% in Q2 |
January 28, 2020 |
| SOM - Appendix 4C |
January 28, 2020 |
| AGM addresses to Shareholders |
November 21, 2019 |
| Results of Meeting |
November 21, 2019 |
| SomnoMed Limited signs agreement with App-Nea LLC |
October 30, 2019 |
| SOM - Appendix 4C |
October 28, 2019 |
| Strong North American revenue growth in Q1 |
October 28, 2019 |
| Notice Of Annual General Meeting |
October 9, 2019 |
| SomnoMed Proxy 2019 |
October 9, 2019 |
| Appendix 4G |
September 23, 2019 |
| SOM Annual Report 2019 |
September 23, 2019 |
| Appointment Sales & Marketing Exec. VP North America |
September 17, 2019 |
| SelectEquities - Recommendation: Accumulate |
September 11, 2019 |
| SOM - Appendix 3B |
September 3, 2019 |
| SOM - Appendix 3Y |
September 1, 2019 |
| Wilsons - BUY: And suddenly, Germany |
August 22, 2019 |
| ASX SOM Preliminary Accounts FY19 |
August 21, 2019 |
| Investor Presentation FY2019 |
August 21, 2019 |
| Investor Presentation FY2019 |
August 21, 2019 |
| Morgans - Muddy result, clearer outlook |
August 21, 2019 |
| Wilsons - BUY: US sales growth equals margin and EPS |
July 25, 2019 |
| SOM - Appendix 4C |
July 23, 2019 |
| Wilsons - New BUY: Back to doing what they are world’s best at |
February 21, 2019 |
| SOM - Appendix 4C |
January 29, 2019 |
| AGM Results for ASX 2018 |
November 27, 2018 |
| AGM addresses to Shareholders |
November 27, 2018 |
| Morgans - Pain for no gain |
November 27, 2018 |
| Change in Leadership of SomnoMed |
November 19, 2018 |
| NVA CEO Key Terms |
November 19, 2018 |
| SOM - Appendix 3B |
November 19, 2018 |
| SOM - Appendix 4C |
October 26, 2018 |
| Notice Of Annual General Meeting |
October 15, 2018 |
| SomnoMed Proxy 2018 |
October 15, 2018 |
| SOM - Appendix 3B |
October 3, 2018 |
| SOM Annual Report 2018 |
September 19, 2018 |
| Wilsons - HOLD: RSS pull-back a necessary mea culpa |
August 23, 2018 |
| SOM - Appendix 3X – Initial Director’s Interest Notice |
May 1, 2018 |
| SOM - Appendix 4C |
April 29, 2018 |
| Form 604 - Notice of change of interests of substantial holder |
March 22, 2018 |
| SOM - Appendix 3B - Institutional Entitlements |
March 22, 2018 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice (LA) |
March 22, 2018 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice (RS) |
March 22, 2018 |
| Shareholding distribution – Analysis of Holdings as at 22-03-2018 |
March 22, 2018 |
| Wilsons - HOLD: Recapitalising the US direct-to-patient market channel |
March 16, 2018 |
| SOM - Appendix 3B - Institutional Entitlements |
February 27, 2018 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - PN |
February 27, 2018 |
| Announcement of Dispatch of Entitlement Offer |
February 26, 2018 |
| SomnoMed – Successful completion of Institutional Entitlement Offer |
February 21, 2018 |
| SomnoMed – Retail Entitlement Offer |
February 20, 2018 |
| SOM - Appendix 3B |
February 19, 2018 |
| SomnoMed – Announcement of Entitlement Offer |
February 19, 2018 |
| Trading Halt |
February 19, 2018 |
| Investor presentation – First half results 2017/18 and Accelerated Entitlement Offer |
February 18, 2018 |
| SomnoMed – Cleansing Notice |
February 18, 2018 |
| SomnoMed – Ineligible Shareholders Letter |
February 18, 2018 |
| ASX Announcement Q2 |
January 24, 2018 |
| SOM - Appendix 4C |
January 24, 2018 |
| Form 605 - Notice of ceasing to be a substantial holder |
December 12, 2017 |
| Morgans - Coming into a seasonally strong period |
November 21, 2017 |
| AGM Results for ASX 2017 |
November 20, 2017 |
| Wilsons - BUY: Scrappy 1Q – Europe the powerhouse supporting outlook and RSS investment |
November 1, 2017 |
| ASX Announcement Q1 |
October 26, 2017 |
| SOM - Appendix 4C |
October 26, 2017 |
| Notice of AGM of SomnoMed 2017 |
October 16, 2017 |
| SOM - Appendix 3B |
October 5, 2017 |
| SOM - Appendix 3Y |
October 4, 2017 |
| SOM Annual Report 2017 |
September 25, 2017 |
| SOM - Appendix 3B |
September 12, 2017 |
| Form 604 - Notice of change of interests of substantial holder |
September 8, 2017 |
| Wilsons - BUY: RSS network shaping up nicely |
August 28, 2017 |
| ASX Preliminary final report |
August 24, 2017 |
| Investors Presentation FY17 |
August 24, 2017 |
| Form 604 - Notice of change of interests of substantial holder |
May 12, 2017 |
| Wilsons - BUY: US channel conflicts abating in Q4 |
April 27, 2017 |
| Morgans - A transitional year |
April 26, 2017 |
| Renew Sleep Solutions well ahead of plan |
April 26, 2017 |
| SOM - Appendix 4C - Quarterly report for entities subject to Listing Rule 4.7B – 26.4.17 |
April 26, 2017 |
| Wilsons - An eye on RSS channel conflict but the core offering to prevail in US direct market |
February 24, 2017 |
| Morgans - Sleeping beauty |
February 23, 2017 |
| SOM - Appendix 4D and Half-Year Financial Report |
February 23, 2017 |
| Wilsons - RSS taking patients in Oklahoma; good Q2 |
January 24, 2017 |
| Wilsons - Record Q1, SCA progress and France ratchets up reimbursement for oral appliance therapy |
October 19, 2016 |
| Notice of AGM of SomnoMed 2016 |
October 12, 2016 |
| SomnoMed Proxy 2016 |
October 12, 2016 |
| SOM - Appendix 3B |
October 7, 2016 |
| SOM Annual Report 2016 |
September 22, 2016 |
| FDA 510k approval for SomnoDent® Alpha |
September 21, 2016 |
| SOM - Appendix 3B |
September 1, 2016 |
| Form 604, Notice of change of interests of substantial holder |
August 26, 2016 |
| Form 605 Notice of ceasing to be a substantial holder |
August 26, 2016 |
| SOMApp3YPN |
August 26, 2016 |
| SOM - Appendix 3B |
August 25, 2016 |
| Wilsons - Organic goodness |
August 19, 2016 |
| Investor Presentation FY 2015-2016 |
August 18, 2016 |
| Morgans - Building for growth |
August 18, 2016 |
| SOM Preliminary Accounts FY16 |
August 18, 2016 |
| CEO appointed for new Direct To Patient business entity |
July 27, 2016 |
| Wilson HTM - Exciting FY17 ahead for core earnings, SCA clinic roll-out and new management |
July 25, 2016 |
| Q4 ASX June 2016 Quarter Final |
July 21, 2016 |
| SOM - Appendix 4C – Quarterly report for entities admitted on the basis of commitments |
July 21, 2016 |
| Derek Smith appointed Global CEO of SomnoMed |
July 19, 2016 |
| Form 603 - Notice of Initial Substantial Holder |
July 19, 2016 |
| Form 604 - Notice of change of interests of substantial holder |
June 6, 2016 |
| SOM - Appendix 3B |
June 6, 2016 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - LA |
June 6, 2016 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - PN |
June 6, 2016 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - RS |
June 6, 2016 |
| Shareholding Information - Post Entitlement Offer |
June 6, 2016 |
| Results of Retail Entitlement Offer |
June 1, 2016 |
| SomnoMed – Results of Institutional Offer |
June 1, 2016 |
| Wilson HTM – MAS Appeal |
June 1, 2016 |
| Morgans - Moving down the supply chain |
May 29, 2016 |
| SOM - Appendix 3B |
May 13, 2016 |
| Dispatch of letters to shareholders and Retail entitlement offer information booklet |
May 10, 2016 |
| Announcement of Entitlement Offer |
May 3, 2016 |
| Cleansing Notice |
May 3, 2016 |
| Investor Presentation - Sleep Centres America Inc. and Pro rata accelerated entitlement issue |
May 3, 2016 |
| Letter To Ineligible Shareholders For The Accelerated Non-Renounceable Entitlements Offer |
May 3, 2016 |
| SOM Chair Letter May 2016 |
May 3, 2016 |
| SomnoMed - Appendix 3B |
May 3, 2016 |
| SomnoMed – Letter To Ineligible Shareholders For The Accelerated Non-Renounceable Entitlements Offer |
May 3, 2016 |
| SOM - Appendix 4C - Quarterly report for entities admitted on the basis of commitments |
April 20, 2016 |
| Investor Presentation FY 2015-16 Half Year Review |
February 18, 2016 |
| SOM - Appendix 4D and Half-Year Financial Report |
February 18, 2016 |
| SelectEquities - Recommendation: Buy |
January 20, 2016 |
| SOM - Appendix 4C - Quarterly report for entities admitted on the basis of commitments |
January 19, 2016 |
| Somnomed records 30% growth in direct sales revenues of Somnodent® devices in 1st half of 2015/16 |
January 19, 2016 |
| Wilson HTM - Sustained European growth underpins a solid Q2 – upgrading FY16 |
January 19, 2016 |
| Form 603 - Notice of Initial substantial holder |
January 6, 2016 |
| Frost & Sullivan Recognises Somnomed Limited As Obstructive Sleep Apnea Company Of The Year At The Annual Australian Excellence Awards |
December 10, 2015 |
| ASX Announcement |
November 25, 2015 |
| SOM - Appendix 3B - New issue announcement, application for quotation of additional securities and agreement |
November 25, 2015 |
| SOM - Appendix 4D - Change of Director’s Interest Notice- PN |
November 25, 2015 |
| SOM - Appendix 3B - New issue announcement, application for quotation of additional securities and agreement |
November 6, 2015 |
| SomnoMed acquires Strong Dental, Canada |
November 3, 2015 |
| SOM - Appendix 3B |
October 30, 2015 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - LA |
October 30, 2015 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - PN |
October 30, 2015 |
| Notice Of Annual General Meeting 2015 |
October 23, 2015 |
| SomnoMed Proxy 2015 |
October 23, 2015 |
| SomnoMed exceeds 250,000 patients |
October 22, 2015 |
| SOM - Appendix 4G - Key to Disclosures Corporate Governance Council Principles and Recommendations |
September 28, 2015 |
| SOM Annual Report 2015 |
September 28, 2015 |
| Form 603 - Notice of initial substantial holder |
September 7, 2015 |
| ASX Preliminary final report – 30 June 2015 |
August 20, 2015 |
| Investor Presentation FY 2014-15 |
August 20, 2015 |
| SOM - Appendix 4C - Quarterly report for entities admitted on the basis of commitments |
August 13, 2015 |
| SOM - Appendix 3B |
July 31, 2015 |
| SOM - Appendix 4C |
July 15, 2015 |
| SomnoMed Announcement – Strong Finish to Financial Year |
July 15, 2015 |
| Form 605 - Notice of ceasing to be a substantial holder |
July 2, 2015 |
| Somnomed receives fda 510(k) approval for somnodent® Devices with wearable compliance micro-recording |
June 22, 2015 |
| Somnomed To Acquire 100% Of SMH Biomaterial AG |
May 25, 2015 |
| SomnoMed Update |
May 20, 2015 |
| SOM - Appendix 3B |
May 7, 2015 |
| Continuous Growth of SomnoMed in Third Quarter |
April 10, 2015 |
| SOM - Appendix 4С |
April 10, 2015 |
| Form 605 - Notice of ceasing to be a substantial holder |
March 11, 2015 |
| Addition of SomnoMed to Australian All Ordinaries Index |
March 6, 2015 |
| Form 605 - Notice of ceasing to be a substantial holder |
February 27, 2015 |
| SOM - Appendix 3B |
February 24, 2015 |
| Investor Presentation FY 2014 – 15 Half Year Review |
February 18, 2015 |
| SOM - Appendix 4D and Half-Year Financial Report |
February 18, 2015 |
| SOM - Appendix 4С |
January 28, 2015 |
| SomnoMed Achieves Growth Targets |
January 28, 2015 |
| Wilson HTM - 2QFY15 – undeniable strategic value in the sleep market |
January 28, 2015 |
| SOM - Appendix 3B |
January 23, 2015 |
| Form 604 - Notice of change of interests of substantial holder |
December 22, 2014 |
| SOM - Appendix 3B |
December 22, 2014 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - RS |
December 19, 2014 |
| Form 604 - Notice of change of interests of substantial holder |
December 3, 2014 |
| SOM - Appendix 3B |
December 3, 2014 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - LA |
December 3, 2014 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - PN |
December 3, 2014 |
| SOM - Appendix 3Y - Change of Director’s Interest Notice - RS |
December 3, 2014 |
| ASX Announcement - General Meeting |
November 26, 2014 |
| Form 604 - Notice of change of interests of substantial holder |
November 26, 2014 |
| SomnoMed Exceeds 200,000 Patients |
November 10, 2014 |
| Investor Presentation |
November 1, 2014 |
| Morgans - Sleeping easy |
October 31, 2014 |
| Notice Of Annual General Meeting |
October 23, 2014 |
| Notice of Annual General Meeting |
October 23, 2014 |
| SOM - Appendix 3B |
October 21, 2014 |
| Wilson HTM - Strong Q1. Stock fairly valued, move to a HOLD |
October 17, 2014 |
| New Records in September Confirm Guidance |
October 16, 2014 |
| SOM - Appendix 4С - Quarterly report for entities admitted on the basis of commitments |
October 16, 2014 |
| SOM Annual Report 2014 |
September 29, 2014 |
| US Medicare reimbursement approval granted for SOMNODENT® Herbst Advance |
September 23, 2014 |
| 2014 Share Purchase Plan – Closes Oversubscribed |
August 22, 2014 |
| SOM - Appendix 3B |
August 22, 2014 |
| SOM - Appendix 3Y – Change of Director’s Interest Notice - LA |
August 22, 2014 |
| ASX Preliminary final report – 30 June 2014 |
August 21, 2014 |
| Investor Presentation FY 2013/14 |
August 21, 2014 |
| Form 604 - Notice of change of interests of substantial holder |
August 11, 2014 |
| Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) |
August 8, 2014 |
| SOM - Appendix 3B |
August 8, 2014 |
| Share Placement Update |
August 8, 2014 |
| Wilson HTM - Cashing up before cashing in |
July 28, 2014 |
| SomnoMed USA receives 510K for SomnoDent® Fusion |
July 24, 2014 |
| Guidance FY 2014/15 |
July 23, 2014 |
| SOM - Appendix 4C |
July 23, 2014 |
| SOM - Appendix 3B |
July 22, 2014 |
| Wilson HTM - Always building something new |
July 15, 2014 |
| SomnoMed takes over Italian Distribution |
July 10, 2014 |
| SomnoMed launches two new products in USA |
June 2, 2014 |
| SomnoMed starts business in Spain and Portugal |
May 26, 2014 |
| SomnoMed enters UK - Ireland market |
May 16, 2014 |
| SOM - Appendix 3B |
May 6, 2014 |
| SomnoMed achieves 28% volume growth in Q3 |
April 10, 2014 |
| Form 605 - Notice of ceasing to be a substantial holder |
March 20, 2014 |
| Form 604 - Notice of change of interests of substantial holder |
March 4, 2014 |
| Wilson HTM - 1HFY14 result |
March 3, 2014 |
| SelectEquities - Recommendation: Speculative Buy |
February 28, 2014 |
| SOM Annual Report 2013 |
September 24, 2013 |
| Wilson HTM - FY14 – further investment in market development |
September 10, 2013 |
| Somnomed Signs Exclusive Agreement For Compliance Measurement |
December 11, 2012 |
| SOM - Appendix 3B |
December 6, 2012 |
| Results of General Meeting |
November 21, 2012 |
| SOM - Appendix 3B |
November 21, 2012 |
| SOM - Appendix 3Y – Change of Director’s Interest Notice - PN |
November 21, 2012 |
| Continuing Global Growth for SomnoMed |
October 22, 2012 |
| SOM - Appendix 4C |
October 22, 2012 |
| SomnoMed Acquired 2nd Largest OA Company in France |
October 9, 2012 |
| SOM Annual Report 2012 |
September 27, 2012 |
| SomnoMed Appoints New Head For North American Region |
September 27, 2012 |
| SomnoMed continues to break records in 4th Quarter |
September 26, 2012 |
| Somnomed Appoints Vp Managed Care For Its North American Operation |
September 24, 2012 |
| Somnomed Partners With Burkhart Dental Supply |
September 12, 2012 |
| SOM - Appendix 3B |
September 11, 2012 |
| ASX Preliminary final report – 30 June 2012 |
August 31, 2012 |
| SOM - Appendix 4C |
July 26, 2012 |
| Investor Presentation FY 2011 - 2012 |
July 1, 2012 |
| SOM Annual Report 2011 |
September 22, 2011 |
| SOM Annual Report 2010 |
September 24, 2010 |
